Phillip G. Febbo, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 16,074 shares at $32.86 ($536K) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Scheduled sale ($536k) by Chief Scientific & Med Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.86 | 4,467 | $147K | 27.4% |
| 2 | $32.86 | 4,467 | $147K | 27.4% |
| 3 | $33.95 | 3,570 | $121K | 22.6% |
| 4 | $33.95 | 3,570 | $121K | 22.6% |
| Total | $33.34 avg | 16,074 | $536K | 100% |
| Filing → |
| VCYT | SELL | 2025-10-07 | $601K | — | Filing → |
| VCYT | SELL | 2024-12-06 | $347K | — | Filing → |
| ILMN | SELL | 2022-04-07 | $1.4M | — | Filing → |